Song-Bai Liu

The impact of FLT3 mutations on treatment response and survival in Chinese de novo AML patients.

[Expression and purification of FLT3 and FLT3-ITD mutated proteins in HEK293T cells].

Impact of -ITD length on prognosis of acute myeloid leukemia.

Pattern and prognostic value of FLT3-ITD mutations in Chinese de novo adult acute myeloid leukemia.

The Role of FLT3-ITD Mutation on de Novo MDS in Chinese Population.

[Mutation Spectrum of FANCJ Gene in Adult Acute Myeloid Leukemia].

Transcriptome Analysis of FEN1 Knockdown HEK293T Cell Strain Reveals Alteration in Nucleic Acid Metabolism, Virus Infection, Cell Morphogenesis and Cancer Development.

CLIC4 abrogation promotes epithelial-mesenchymal transition in gastric cancer.

FEN1 inhibitor increases sensitivity of radiotherapy in cervical cancer cells.

The Clinical and Molecular Characteristics of FLT3 Mutations in Chinese De Novo Adolescent and Adult Acute Lymphoblastic Leukemia Patients.

DAXX inhibits cancer stemness and epithelial-mesenchymal transition in gastric cancer.

PD1 inhibitor in combination with 5-azacytidine and low-dose DLI for the successful treatment of AML patients who relapsed after transplantation.

FEN1 Status and Its Correlation with Clinicopathologic Characteristic in Colorectal Cancer.

Correction to: PD1 inhibitor in combination with 5-azacytidine and low-dose DLI for the successful treatment of AML patients who relapsed after transplantation.

Venetoclax combined with azacitidine as an effective and safe salvage regimen for relapsed or refractory T-cell acute lymphoblastic leukemia: a case series.

[Effect of FLT3-ITD Length on 32D Cell Proliferation, Apoptosis and Sensitivity to FLT3 Inhibitor].

A Combined Histone Deacetylases Targeting Strategy to Overcome Venetoclax Plus Azacitidine Regimen Resistance in Acute Myeloid Leukaemia: Three Case Reports.

An 11-Gene Signature Based on Treatment Responsiveness Predicts Radiation Therapy Survival Benefit Among Breast Cancer Patients.

Rapid and Efficient Response to Gilteritinib and Venetoclax-Based Therapy in Two AML Patients with FLT3-ITD Mutation Unresponsive to Venetoclax Plus Azacitidine.

A Radiosensitivity Prediction Model Developed Based on Weighted Correlation Network Analysis of Hypoxia Genes for Lower-Grade Glioma.

Integration of immune and hypoxia gene signatures improves the prediction of radiosensitivity in breast cancer.

Development and Validation of Prognostic Model for Lung Adenocarcinoma Patients Based on m6A Methylation Related Transcriptomics.

Developments and challenges of FLT3 inhibitors in acute myeloid leukemia.

Comprehensive analysis of ERCC3 prognosis value and ceRNA network in AML.

Loss of CRY2 promotes regenerative myogenesis by enhancing PAX7 expression and satellite cell proliferation.

Case Report: Blinatumomab therapy for the treatment of B-cell acute lymphoblastic leukemia patients with central nervous system infiltration.

Mutation spectrum of FLT3 and significance of non-canonical FLT3 mutations in haematological malignancy.

High FAAP24 expression reveals poor prognosis and an immunosuppressive microenvironment shaping in AML.

The roles of TPL in hematological malignancies.

Inhibition of FEN1 promotes DNA damage and enhances chemotherapeutic response in prostate cancer cells.

Zyxin inhibits the epithelial-mesenchymal transition process in gastric cancer by upregulating SIRT1.

Types of DNA damage and research progress.

Development and validation of a cuproptosis-related prognostic model for acute myeloid leukemia patients using machine learning with stacking.

Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunity.

Investigations of the prognostic value of RUNX1 mutation in acute myeloid leukemia patients: Data from a real-world study.

Research progress on morphology and mechanism of programmed cell death.

Deletion of TECRL promotes skeletal muscle repair by up-regulating EGR2.